| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.921956651202994 3.3754924990660364 0.0007368370062825 0.3611988301308909 0.0111999224954951 3 Q14145 1 |
| Fatty acid betaoxidation 0.7380603348410005 3.068774573863463 0.0021493871129425 0.7297029715598624 0.0204191775729542 19 P11310,P23786,O43772,P42126,P43304,Q16836,P30084,P50416 8 |
| Eicosanoid synthesis 0.7388081826267472 2.901867411575417 0.0037094550469243 0.8956017221355564 0.0292902424484414 2 Q9H7Z7 1 |
| Mitochondrial long chain fatty acid betaoxidation 0.793552016068389 2.794923142591238 0.0051912055130096 0.9577636389987552 0.0371323876695279 13 O43772,P23786,P11310,Q9BY49,Q16836 5 |
| Oligodendrocyte specification and differentiation leading to myelin components for cns 0.7121257041209712 2.7631682891490303 0.0057243243731557 0.9695109853682926 0.0391054968413335 2 Q99640 1 |
| Sarscov2 and covid19 pathway 0.7802647958603257 2.723239766127972 0.0064645122725632 0.9806135830353082 0.0431914666122909 3 Q8WTV0 1 |
| Metabolism of spingolipids in er and golgi apparatus 0.91339542495794 2.7025274047988463 0.006881451142215 0.9849801768642475 0.0449884117684597 5 Q9NRA0 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.764745297132911 2.646196253240201 0.0081402574531188 0.9930535928864116 0.0510234693968687 13 Q32P28,O15460,P13674,O75718,Q96AY3 5 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8913844452672035 2.6106837415937902 0.0090361415404816 0.9959899307642328 0.0543957827387407 5 Q15392 1 |
| Sars coronavirus and innate immunity 0.7497724873833923 2.575656178915513 0.0100050077918989 0.9977876051311296 0.0579337594045196 3 Q7Z434 1 |
| Folatealcohol and cancer pathway hypotheses 0.6744737622294787 2.5632767314793052 0.010368936648103 0.9982307962689888 0.0590823066765898 2 Q99707 1 |
| Reninangiotensinaldosterone system raas 0.7469274464808249 2.561749450397552 0.0104146420676503 0.9982797857069804 0.0590823066765898 3 Q13555 1 |
| Sulfation biotransformation reaction 0.735620563504055 2.5062483493673833 0.012201988140128 0.9994268955044494 0.065077270080683 3 P00390 1 |
| Tryptophan metabolism 0.7037858996229415 2.4744706315849823 0.0133433790897232 0.9997162414199168 0.0701844607432393 15 P35610,O94788,Q15392,Q16836,P30084 5 |
| Atr signaling 0.7289261036623217 2.4732123195887 0.0133904563260127 0.9997243552048884 0.0701844607432393 3 O14757 1 |
| Sarscov2 b117 variant antagonises innate immune activation 0.7271834317410386 2.4645910613754163 0.0137169703715609 0.9997746026463904 0.071281350306915 3 Q7Z434 1 |
| Sting pathway in kawasakilike disease and covid19 0.7241992882562243 2.449807440753413 0.0142932630049097 0.9998420146935204 0.0730277639242447 3 Q9UHD2,Q86UT6 2 |
| Vitamin a and carotenoid metabolism 0.8517679899969703 2.442792744321134 0.0145741042407554 0.9998671461180104 0.0738421281531609 5 Q8WTV0,O94788,P09455 3 |
| Ppar signaling pathway 0.6808314965086992 2.4282964120742903 0.0151699394186444 0.9999080253400416 0.0756010095617689 16 P11310,P23786 2 |
| Alzheimers disease and mirna effects 0.4038114008330785 2.4119851755964685 0.0158659266141014 0.9999401594937646 0.0771718670509895 88 P49841,Q12933,Q13885,P07384,Q96BY7,Q9NQC3,O95197,P49721,Q96GC9,P60900,Q9Y4P8,P12235,P07437,P68371,P28074,P31751 16 |
| Pparalpha pathway 0.8391997463953254 2.255710897118881 0.024088742673191 0.999999635683163 0.1084648456756378 7 P11310,P23786 2 |
| Circadian rhythm genes 0.4882102462428079 2.244863230394069 0.0247769140662159 0.9999997627447016 0.1084648456756378 44 P00813,Q14103,P49841,P43490 4 |
| Alzheimers disease 0.3938820340168789 2.2435941499408805 0.0248585260063096 0.9999997745149376 0.1084648456756378 86 P49841,Q12933,Q13885,P07384,Q96BY7,Q9NQC3,O95197,P49721,P60900,Q9Y4P8,P12235,P07437,P68371,P28074,P31751 15 |
| Cytosine methylation 0.751402184006533 2.24188563017321 0.0249687649992369 0.9999997894935916 0.1084648456756378 4 P48735 1 |
| Statin inhibition of cholesterol production 0.7973293768545857 2.2066120164995304 0.0273411767291942 0.9999999521366932 0.1170664468404936 5 Q14534,Q8WTV0,P35610,P37268 4 |
| Methylation pathways 0.6651838671411585 2.152086414709512 0.0313905489291894 0.9999999962119912 0.1299313490917137 3 P31153,P21964 2 |
| Microrna network associated with chronic lymphocytic leukemia 0.5997628224132869 2.151784605393938 0.0314143228889505 0.9999999962681004 0.1299313490917137 2 Q07820 1 |
| Mitochondrial complex ii assembly 0.5953157426623213 2.126665276866778 0.0334479045471427 0.9999999989601704 0.1329171631677306 2 P31040 1 |
| Thermogenesis 0.5290645801741614 2.081661047902049 0.0373734409393766 0.9999999999124276 0.1466003360718775 27 O43772,P23786,P51812,Q15418 4 |
| Type i interferon induction and signaling during sarscov2 infection 0.7150082666583826 2.070873813213228 0.0383705899514668 0.999999999953366 0.1495469146826398 4 Q7Z434 1 |
| Ptf1a related regulatory pathway 0.6408659549228839 2.0264683965170582 0.0427168081414537 0.9999999999970312 0.16131564813667 3 O00330,Q06330 2 |
| Triacylglyceride synthesis 0.7540955530566629 2.014565718087378 0.0439501725253399 0.9999999999986444 0.1641703448506215 5 Q9HCL2 1 |
| Glycogen synthesis and degradation 0.5532088766214793 2.003459998404526 0.0451279370605821 0.9999999999993592 0.1673035715416704 20 P49841,P13807,P46020,Q16537 4 |
| Erk pathway in huntingtons disease 0.633649958185074 1.988871335942028 0.0467154063599615 0.999999999999767 0.1690652801598607 3 P42858 1 |
| Ketogenesis and ketolysis 0.7880263021614826 1.9373581266148032 0.0527015814524127 0.9999999999999948 0.1862939623434125 6 O43772 1 |
| Ccl18 signaling pathway 0.665458008813147 1.9137085802353329 0.0556574021123132 0.9999999999999992 0.1944810372660143 11 Q86UE4,Q96GC9,P08670,P19022,P00403 5 |
| Angiopoietinlike protein 8 regulatory pathway 0.4965389651294599 1.8961905422686995 0.0579348533427417 0.9999999999999998 0.1990078578100959 29 P49841,P13807,Q15418,P51812,P31751 5 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.6106168446025955 1.8679090488672383 0.0617747493818903 1.0 0.2085942554471883 3 P42574,Q07820 2 |
| Ethanol effects on histone modifications 0.6548779758717694 1.8581731861958988 0.0631444244753045 1.0 0.2109440114339844 11 P05091,P41440,O94788,Q99707,O14929 5 |
| Metapathway biotransformation phase i and ii 0.5260395707461555 1.8161566308864256 0.069346348681005 1.0 0.2303966120112081 20 Q6UW02,Q16850,P07099 3 |
| Insulin signaling 0.4339040584795749 1.7831106420526772 0.0745682944312562 1.0 0.2463995815989336 46 P49841,Q9Y496,Q12846,P41440,P13807,O00443,P46976,O60343,Q15833,O00161,P33176,Q15418,P49840,Q13131,P51812,Q02750,P31751,Q96PE3 18 |
| Cytosolic dnasensing pathway 0.5950020537822069 1.778857374225163 0.0752631480013721 1.0 0.2473513188369419 14 Q7Z434,Q13546,P62875,Q9BUI4,Q86UT6,Q9UHD2 6 |
| Oxidation by cytochrome p450 0.7462531692828952 1.757723816978006 0.0787945133422842 1.0 0.2548248091069618 6 Q6UW02,Q16850 2 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.497351369976098 1.7324773089295722 0.0831886137677835 1.0 0.2634306102646478 24 P35610,Q15800,Q14534,Q15392,Q16850,Q9BWD1 6 |
| Riboflavin and coq disorders 0.7188911055289935 1.726595125874614 0.0842404019173985 1.0 0.2644490020461688 7 Q8NI60,Q8NFF5 2 |
| Foxa2 pathway 0.6427197343449413 1.7221457515550591 0.0850431190054843 1.0 0.2651600838735101 4 P28161,O15439 2 |
| Apoptosis modulation by hsp70 0.6857566765578537 1.7034081545034503 0.0884917127268196 1.0 0.2731114788726211 5 Q13546,P19838,P42574,O95831 4 |
| Leptin and adiponectin 0.6372214881749416 1.695170973496497 0.0900429915643017 1.0 0.2764956508641185 4 P50416 1 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.7093377295971506 1.683472623518434 0.0922836347313571 1.0 0.2814274167025338 7 P07099,P48507,Q14145 3 |
| Amino acid metabolism 0.3912984989147756 1.6819692227802006 0.0925748081258335 1.0 0.2814274167025338 56 P11310,O15460,Q16836 3 |
| Nad biosynthetic pathways 0.6748160868889476 1.6528172274690949 0.0983680668728019 1.0 0.2937329146951827 5 P43490 1 |
| Nad metabolism 0.6748160868889476 1.6528172274690949 0.0983680668728019 1.0 0.2937329146951827 5 P43490 1 |
| Vitamin b12 disorders 0.6284253737947569 1.6518990945995211 0.0985551226937784 1.0 0.2937329146951827 4 Q96EY8 1 |
| Relationship between inflammation cox2 and egfr 0.62072211675721 1.6138899217010565 0.106551305095613 1.0 0.3144815218355958 4 P31751 1 |
| Overview of interferonsmediated signaling pathway 0.5060776756596613 1.608757244544297 0.1076694331878846 1.0 0.3162464511025791 2 P42224 1 |
| Map3k1 role in promoting and blocking gonadal determination 0.6646905628027916 1.6058288215228764 0.1083115261572404 1.0 0.3166029226134721 5 P49841 1 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.6596389303456683 1.582329880502595 0.1135742828325057 1.0 0.3272661799154667 5 P19838,P48507,Q14145 3 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.5705879836409791 1.5779763949868424 0.1145710327777336 1.0 0.3285810751361417 13 P49841,Q12933 2 |
| 1q211 copy number variation syndrome 0.6442866054192004 1.5725240675472465 0.1158290620254911 1.0 0.3306294352652517 9 Q9NPH0,Q9UDY2 2 |
| Nrf2are regulation 0.6410437331085782 1.55653068681465 0.119581951434434 1.0 0.3370869090122562 9 P49841,Q14145 2 |
| Dna mismatch repair 0.4854776121758577 1.5557604288775222 0.1197650710590911 1.0 0.3370869090122562 21 Q9UQ84,P35251,P41440,P18858,Q9NR33,P49005,Q07864 7 |
| Erbb signaling pathway 0.5011140860425773 1.5534780088360556 0.1203089790389138 1.0 0.3370869090122562 19 P49841,Q16512,P31751 3 |
| Fatty acid biosynthesis 0.5338568861387791 1.5408677288946486 0.1233489813891177 1.0 0.3424483136282356 16 Q9BY49,Q16836 2 |
| Urea cycle and related diseases 0.4924399644233697 1.5275810813575288 0.1266165819080793 1.0 0.3481851906170247 2 Q9Y619 1 |
| Adipogenesis 0.5300358936180309 1.5169566569887862 0.1292776274972138 1.0 0.3524699440282781 16 Q9NZ45,P43490 2 |
| Glutathione metabolism 0.6708781492213908 1.5085563474560455 0.1314121967525867 1.0 0.3566902483284497 7 P00390,P48507,O75874 3 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.6267973337011798 1.486100372180864 0.1372525738814463 1.0 0.3692458624775192 9 P49841 1 |
| Regulation of sister chromatid separation at the metaphaseanaphase transition 0.5968308425894019 1.4393968758812996 0.1500381090119762 1.0 0.3949054990445089 10 Q02224,Q12834,Q8WVM7 3 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.6348935556503573 1.4292261087820626 0.1529392558221676 1.0 0.3956896491058634 8 Q15418 1 |
| B cell receptor signaling pathway 0.4657545203220732 1.391557808416372 0.164056342735934 1.0 0.4226536287434233 20 P49841 1 |
| Copper homeostasis 0.606368656451717 1.384702345405341 0.1661435016324115 1.0 0.4253394521549534 9 P49841,O75880,O43819,Q8N668 4 |
| Ampactivated protein kinase ampk signaling 0.5169625186789262 1.373105494573178 0.1697195531699002 1.0 0.4302316964459299 15 P13807,P50416,P31751,P04035 4 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.5678889690546114 1.3508870460880795 0.1767316184048297 1.0 0.4389978984882455 4 P08670 1 |
| Sphingolipid metabolism integrated pathway 0.5951614927987215 1.3289269037240463 0.1838720868086982 1.0 0.4507831805632603 9 Q96G23,Q9NRA0,O15121 3 |
| Sphingolipid metabolism overview 0.5951614927987215 1.3289269037240463 0.1838720868086982 1.0 0.4507831805632603 9 Q96G23,Q9NRA0,O15121 3 |
| Il5 signaling pathway 0.5331067051265542 1.313158378410141 0.1891295857219974 1.0 0.4562388241485079 12 P49841 1 |
| Dna repair pathways full network 0.3677312359686394 1.3096474257991677 0.1903151367049167 1.0 0.4562388241485079 53 Q9UQ84,P12956,P41440,P49005,O14757,O15360,P41208 7 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.6308465935746639 1.2495709808788995 0.2114563092589767 1.0 0.4798610331647785 6 Q14145 1 |
| Genes related to primary cilium development based on crispr 0.4673537711170151 1.2479474319394586 0.2120503088711713 1.0 0.4798610331647785 18 Q9Y496,Q9ULC3,P63167,O75386,A0AVF1,Q86SX3,O95684,Q7Z4L5 8 |
| Somatroph axis gh and its relationship to dietary restriction and aging 0.4441150311295586 1.237374414487334 0.2159481129174718 1.0 0.4844887551801582 2 Q96EB6 1 |
| Allograft rejection 0.5759005071038343 1.2329430537282973 0.2175970109969078 1.0 0.4863933186989705 9 P10321,P08670,Q9BY49,P04439 4 |
| Autophagy 0.5897751500179003 1.2134843933324344 0.2249446776822641 1.0 0.4991473139810824 8 Q9NT62,Q9Y4P8 2 |
| Chemokine signaling pathway 0.4242287921397039 1.209273773032429 0.2265576833736524 1.0 0.5008984417861116 25 P49841,Q16512,Q13464,P31751 4 |
| Microglia pathogen phagocytosis pathway 0.4867486718233079 1.1979889138284374 0.2309213329093964 1.0 0.5086962695975109 3 O00443 1 |
| Tca cycle and deficiency of pyruvate dehydrogenase complex pdhc 0.488025526079107 1.1956140869988792 0.2318471916112332 1.0 0.5088920306845841 15 P21399 1 |
| Embryonic stem cell pluripotency pathways 0.5246448532657919 1.157944884790586 0.2468865289670256 1.0 0.5285458084927873 11 P49841 1 |
| Exrna mechanism of action and biogenesis 0.4783511269276182 1.1520125751735335 0.2493159059066134 1.0 0.5300142335357377 3 Q9UPY3,Q9HAV4 2 |
| Praderwilli and angelman syndrome 0.567790395835226 1.1083312655624875 0.2677187774502312 1.0 0.5612862644473813 8 Q7L576,Q15154,P11802 3 |
| Tyrobp causal network in microglia 0.5981057348299964 1.1041581495433608 0.2695245403051274 1.0 0.5631303110155239 6 Q15418 1 |
| Pi3kakt signaling pathway 0.3724339640947057 1.091385987908181 0.2751030754002599 1.0 0.5669921011639255 41 P63000,P49841,Q16537,P23588,P30154,P13807,P11802,Q16512,P07942,P63218,Q9UBI6,Q13131,P24941,P63151,Q02750,P31751 16 |
| Sudden infant death syndrome sids susceptibility pathways 0.3970237785655501 1.068361994702048 0.2853572536111806 1.0 0.5776264786357959 28 P11310,P50416,P12235 3 |
| Cohesin complex cornelia de lange syndrome 0.4585560761117224 1.067019326926657 0.2859631086667344 1.0 0.5776264786357959 16 Q16537,Q7Z5K2,Q6KC79,Q9Y6X3 4 |
| Tolllike receptor signaling related to myd88 0.4563220051370066 1.0317239934390898 0.3022014341073487 1.0 0.6004525226708105 3 Q9UHD2 1 |
| Nuclear receptors metapathway 0.3450997411335965 1.0107072484317807 0.3121565667873094 1.0 0.6142109793096573 51 P11310,P23786,O15439,O00170,P00390,P50416,P28161,Q14145,Q9HCL2,P48507 10 |
| Microtubule cytoskeleton regulation 0.4112109394406069 1.003242543598438 0.3157438507125909 1.0 0.6172741518754189 20 P49841,Q13464 2 |
| Androgen receptor signaling pathway 0.3898002218429814 0.9894791995087194 0.3224287418749605 1.0 0.6263152557826709 27 P49841,Q99497 2 |
| Steroid biosynthesis 0.402312481470504 0.986195135754346 0.3240373657968876 1.0 0.627435408931553 2 Q99829 1 |
| Hair follicle development organogenesis part 2 of 3 0.4928569456984983 0.9755510405837652 0.3292869966227914 1.0 0.6335648542615733 4 P19838,P35222 2 |
| Leptin signaling pathway 0.3822682715731513 0.968927835782216 0.3325811959644029 1.0 0.6358785130388585 29 P49841,Q15418 2 |
| Synaptic vesicle pathway 0.4496095057333158 0.9163568955838324 0.3594797355491024 1.0 0.680273578618317 14 Q99497 1 |
| Vitamin b12 metabolism 0.5265749107907918 0.9127095143555716 0.3613953386409809 1.0 0.680273578618317 8 Q96EY8 1 |
| Cardiac hypertrophic response 0.4469799016199957 0.9009149867497698 0.3676335222405587 1.0 0.6821972006250422 14 P49841 1 |
| Network map of sarscov2 signaling pathway 0.3755832609402215 0.8969288226365424 0.3697568989696376 1.0 0.6833197403451055 28 Q9P253,Q96AX1,Q7Z434,Q12933,P42574,O95067,Q07021,Q9UHD2 8 |
| Translation inhibitors in chronically activated pdgfra cells 0.407312630719406 0.8493646636774379 0.395678409407187 1.0 0.711634325478437 18 Q15418,P31751 2 |
| Integrinmediated cell adhesion 0.3800337009371335 0.8492908327208267 0.395719480640017 1.0 0.711634325478437 24 P07384,Q13464,Q16512,P41240,Q13153,P50552,Q13418,Q02750,P31751 9 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.415336512202478 0.8472502016853605 0.3968556771104314 1.0 0.711634325478437 17 Q8IXJ6,P43490 2 |
| Novel intracellular components of rigilike receptor rlr pathway 0.4431064449698667 0.839758270428742 0.4010439350592696 1.0 0.7150578079649148 13 Q12933,Q7Z434,Q13546,Q86UT6 4 |
| Translation factors 0.3376987738848642 0.7388882340757207 0.4599748674988286 1.0 0.7808544977260248 37 P23588,O75153,Q15056,P55010,Q9NR50 5 |
| Sphingolipid pathway 0.4444435472112254 0.7299780836370507 0.4654035811914501 1.0 0.7822166433672385 11 Q9NRA0,Q96G23 2 |
| Micrornas in cardiomyocyte hypertrophy 0.3718950370769493 0.7294479880706854 0.4657276725311519 1.0 0.7822166433672385 20 P49841,Q13464 2 |
| Cholesterol biosynthesis pathway 0.4171831267521406 0.6948937303577345 0.4871219021028707 1.0 0.8013379144682403 13 Q14534,Q16850,P37268,Q15800 4 |
| Nucleotide excision repair 0.3559744334461412 0.6919411509774909 0.4889742866245348 1.0 0.8013379144682403 25 Q92759,P35251,P41440,P18858,Q9NR33,P49005,P41208 7 |
| Mitochondrial immune response to sarscov2 0.4338334213344355 0.6755842368553059 0.4993046523913644 1.0 0.8070496520148894 11 Q7Z434,Q9H845,Q9BQ95,Q9Y6M9,Q86UT6,Q9UHD2 6 |
| Electron transport chain oxphos system in mitochondria 0.3051118305060733 0.6684418817888194 0.5038515687006164 1.0 0.8070496520148894 54 P31930,O75880,P00846,O43678,O14949,P12235,O43676,P14406,P00403,O95168,Q9Y6N1,P03886 12 |
| Mitochondrial complex i assembly model oxphos system 0.3422074405547771 0.6664027129019212 0.5051537289377874 1.0 0.8070496520148894 30 Q9NPL8,Q7L592,Q9H845,Q9NX14,O43678,Q9BQ95,O43676,O75306,Q96CU9,Q9Y6M9,O95168,P03886 12 |
| Selenium micronutrient network 0.4023374560153748 0.6450533101222542 0.5188926392463205 1.0 0.8215800121400074 14 P00390,Q9C0D9,Q8WTV0,Q8NFF5 4 |
| Oxysterols derived from cholesterol 0.4895413994544845 0.6359118827794438 0.5248338571895725 1.0 0.8266813087338345 6 O14734 1 |
| Sphingolipid metabolism in senescence 0.3992000663722502 0.6276843374102837 0.5302107477421898 1.0 0.8319044461738677 14 Q96G23,O15121 2 |
| Acute viral myocarditis 0.3929814136039085 0.626653501282259 0.530886389992534 1.0 0.8319044461738677 15 P49841,P78344,P42574,Q9NRG0,Q13418 5 |
| Nitric oxide metabolism in cystic fibrosis 0.4168532596075985 0.6103503488536353 0.541629751001347 1.0 0.8400787974714771 4 Q86X55,O60678 2 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.453280274934413 0.5796586160833663 0.5621448562054794 1.0 0.8586623268176401 8 Q7Z434,Q13546,Q9UHD2 3 |
| Ranklrank signaling pathway 0.3759804188936554 0.5657932087866367 0.5715343636229062 1.0 0.8687322327068174 16 Q12933 1 |
| Liver x receptor pathway 0.3276015416543127 0.5580118413118776 0.5768362983028481 1.0 0.8702641919804756 2 P49327 1 |
| Serotonin and anxiety 0.3222650459531555 0.5296774982555091 0.596335551786424 1.0 0.8864841454428991 2 Q08209 1 |
| Biotin metabolism including iems 0.4516736063059346 0.525651182115793 0.5991305883286424 1.0 0.8879376187306365 7 Q9HCC0 1 |
| Glycerophospholipid biosynthetic pathway 0.4512806599386914 0.5240638270877613 0.6002341468721901 1.0 0.8879376187306365 7 Q9HCL2 1 |
| Nonalcoholic fatty liver disease 0.2904409715738688 0.5206298417211459 0.6026246567555542 1.0 0.8893101730761576 54 P49841,Q12933,Q96GC9,O14949,O43676,P14406,P31751 7 |
| Head and neck squamous cell carcinoma 0.3824516502958428 0.5102493250862448 0.6098767997960459 1.0 0.8935062512674601 13 P11802,P31751,Q14145 3 |
| Epithelial to mesenchymal transition in colorectal cancer 0.3345630121968946 0.5012125531649382 0.6162215405745517 1.0 0.9006314823781909 22 P49841,P19022,Q16512,P31751 4 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.3817883770795384 0.4840640215009832 0.6283404340576868 1.0 0.9095975807311276 12 P35610,Q9BWD1,P37268 3 |
| Chromosomal and microsatellite instability in colorectal cancer 0.3331215165258701 0.4759829586173232 0.6340865186749278 1.0 0.9135654107923132 20 P49841,Q9UKG1 2 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3093924805763893 0.4676012438539422 0.6400697752504096 1.0 0.9178359041326628 33 Q14534,P04035,P53992,Q8WTV0,Q16850,P37268,Q9HCL2 7 |
| Pathogenic escherichia coli infection 0.3205971252840764 0.4583416651594585 0.6467069946258854 1.0 0.9195887532037842 26 Q13464,Q13885,P07437 3 |
| Proteasome degradation 0.3009613783974468 0.4554811228192189 0.6487631452443507 1.0 0.9195887532037842 42 P46934,P28072,Q99436,P04439,P49721,P28074,P10321,P60900 8 |
| Cell cycle 0.2849323335724205 0.4482352172287539 0.6539834488733218 1.0 0.922741151321288 53 P49841,O43913,O43683,Q12834,Q99640,O14757,Q9UBD5,Q8WVM7,P24941,Q9Y3B8,Q9UJX3 11 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.3053661428994908 0.4431126730823655 0.6576842390484785 1.0 0.922741151321288 2 P19838 1 |
| Ltf danger signal response pathway 0.3053661428994908 0.4431126730823655 0.6576842390484785 1.0 0.922741151321288 2 P19838 1 |
| Sarscov2 innate immunity evasion and cellspecific immune response 0.367103582982963 0.4336259624983368 0.6645600783892833 1.0 0.9242336241091332 13 Q12933,Q7Z434,Q13546 3 |
| Mapk pathway in congenital thyroid cancer 0.338078291814942 0.4285034056355182 0.6682846546055168 1.0 0.9242336241091332 3 Q02750,P36507 2 |
| Dna damage response 0.3195935252318684 0.4253895226641815 0.6705527425619513 1.0 0.9242336241091332 24 P35251,P41440,P11802,O95067,O14757,Q9BXW9,P24941,Q9Y3B8 8 |
| Nephrotic syndrome 0.3541432436220618 0.4167741475707077 0.6768436136928799 1.0 0.9248320164528252 15 Q9BT22,Q6P4I2,Q86YH6,Q7Z4L5 4 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.3904906717841038 0.4121599498147859 0.6802221901836647 1.0 0.9272984117301976 10 P49841 1 |
| Intraflagellar transport proteins binding to dynein 0.4104149265299215 0.4035865696959418 0.6865167633751865 1.0 0.9280356644526964 8 Q9Y6G9,P63167 2 |
| Kit receptor signaling pathway 0.3461811049519215 0.4031083724404275 0.6868685016508445 1.0 0.9280356644526964 16 Q15418 1 |
| Neurodegeneration with brain iron accumulation nbia subtypes pathway 0.359936540806524 0.3991653606666218 0.689771364826345 1.0 0.9288378983183984 13 O15269,Q9NT62,Q13131,Q9Y4P8 4 |
| Target of rapamycin tor signaling 0.397953828919543 0.3960809083088955 0.6920453420036752 1.0 0.9288378983183984 9 Q13131,P04035 2 |
| Mirna regulation of dna damage response 0.3118637375591043 0.387204458160883 0.6986048499453212 1.0 0.9335341943153952 25 P35251,P41440,P11802,O95067,O14757,Q9BXW9,P24941,Q9Y3B8 8 |
| Fluoroacetic acid toxicity 0.3838658210352119 0.3491813178215183 0.7269531907833069 1.0 0.938165789912892 5 P51648 1 |
| Folate metabolism 0.329179049993443 0.3438820610248291 0.7309349832864254 1.0 0.938165789912892 17 Q8WTV0,Q8NFF5 2 |
| Mitochondrial complex iii assembly 0.3706745991262321 0.3309831641659508 0.7406572025628095 1.0 0.938165789912892 10 P31930,Q9BRT2,O14949,Q6DKK2 4 |
| Burn wound healing 0.3676112002880038 0.3190161451594453 0.7497142698859771 1.0 0.9386438984643604 10 P08670,P19838,P42574,P07737 4 |
| Disorders of folate metabolism and transport 0.3863973863973762 0.3147153462959566 0.7529777912690996 1.0 0.9386438984643604 8 P00374,P11586,P22102,P49914,Q99707,P34897,P04818 7 |
| Spinal cord injury 0.3030829290383661 0.3090792732192189 0.7572612253646769 1.0 0.9386438984643604 22 P24941,P14174,Q9NQC3,P17931 4 |
| 22q112 copy number variation syndrome 0.2840642247660281 0.3051570181580992 0.7602465665737173 1.0 0.9386438984643604 34 O94788,P53007,Q92890 3 |
| Endometrial cancer 0.3387532578231635 0.3030695510276238 0.7618368582909953 1.0 0.9386438984643604 13 P49841 1 |
| Bile acids synthesis and enterohepatic circulation 0.305456702253857 0.292695239365507 0.769755109054699 1.0 0.9386438984643604 3 P27361,P51114 2 |
| Neovascularisation processes 0.3054567022538511 0.2926952393654847 0.7697551090547161 1.0 0.9386438984643604 3 P27361,P19838 2 |
| Integrated cancer pathway 0.332189816772207 0.291082405950424 0.7709882956204597 1.0 0.9386438984643604 14 P11802,P42574,O14757,P53350,P43246,P24941 6 |
| Autosomal recessive osteopetrosis pathways 0.3033807829181477 0.2848000583698487 0.7757973275018881 1.0 0.9386438984643604 3 P51798,P19838 2 |
| Energy metabolism 0.3344308337347174 0.2846354904220964 0.7759234180244403 1.0 0.9386438984643604 13 P49841 1 |
| Mecp2 and associated rett syndrome 0.3040071328233089 0.2736398636083652 0.7843613960732072 1.0 0.9388835823611617 19 P31943,P52597,Q03518,P35637 4 |
| Disruption of postsynaptic signaling by cnv 0.3653293058696882 0.2735090448573892 0.7844619405254443 1.0 0.9388835823611617 9 Q13555,Q14168 2 |
| Mapk signaling pathway 0.2752495041942595 0.2556516143730074 0.798219859866357 1.0 0.9501366515036154 42 P54652,Q12933,Q9Y4G8,Q16512,P51812,P31751 6 |
| Ebola virus infection in host 0.2751018954807946 0.2545947173725599 0.7990361396961978 1.0 0.9501366515036154 42 Q9P253,P63000,Q96AX1,P46934,P19838,O15118,P35251,P04439,P41440,Q16512,Q13153,P10321,Q9UN37,Q07021,P42566,Q9UHD2 16 |
| Transsulfuration and onecarbon metabolism 0.2939013037195314 0.2525172875969464 0.8006412534050682 1.0 0.9501366515036154 20 P78330,P48507,O43865 3 |
| Aryl hydrocarbon receptor pathway wp2586 0.3570973175061865 0.2454562046165026 0.8061032146915217 1.0 0.9505264631735064 9 Q02750,O00170,P24941 3 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.3085861104400557 0.2446302307629272 0.8067427543603627 1.0 0.9505264631735064 17 P49841,P11802,Q16512,Q02750,Q13153,Q9UHD1 6 |
| Ferroptosis 0.290909495697697 0.2426711391103138 0.808260166876156 1.0 0.9505264631735064 22 Q9Y277,Q9NZ45,P04035,P16435,P33121,Q15365,P08195,P37268,P48507 9 |
| Photodynamic therapyinduced unfolded protein response 0.3421945984770582 0.226553385806325 0.8207710425040045 1.0 0.9559938579356988 10 P08243,Q15084,P27797,Q13217 4 |
| Gastrin signaling pathway 0.2796900783585249 0.2145472240090485 0.8301203447644889 1.0 0.9573366258606172 28 P49841,Q13464 2 |
| Focal adhesion pi3kaktmtorsignaling pathway 0.2691454791742494 0.2129431819944712 0.8313712803526414 1.0 0.9573366258606172 42 P49841,Q16537,P23588,P13807,P63218,P31751 6 |
| Tolllike receptor signaling pathway 0.3132433830633725 0.2008241551808005 0.8408360745892494 1.0 0.9627652228818524 13 P63000,Q13546,P31751,Q02750,Q9UHD2 5 |
| Nucleotide excision repair in xeroderma pigmentosum 0.265960499363574 0.1862510984344034 0.8522478541749736 1.0 0.9628745199756116 34 Q92759,Q86WJ1,P41440,P49005,Q93009,P41208 6 |
| Physicochemical features and toxicityassociated pathways 0.2905286004074441 0.1861660900208512 0.8523145153074341 1.0 0.9628745199756116 18 P49841 1 |
| Osteopontin signaling 0.3055473153367044 0.1845258737175552 0.8536009313599571 1.0 0.9628745199756116 4 Q02750,P27361,P19838 3 |
| Serotonin receptor 2 and elksrfgata4 signaling 0.3055473153367037 0.1845258737175535 0.8536009313599584 1.0 0.9628745199756116 4 P27361,Q02750,P36507 3 |
| Serotonin receptor 467 and nr3c signaling 0.3055473153367037 0.1845258737175535 0.8536009313599584 1.0 0.9628745199756116 4 P27361,Q02750,P36507 3 |
| Camkk2 pathway 0.3062741599762226 0.1676229596328119 0.8668799075899867 1.0 0.9705443157053016 12 P63000,Q14012,P27361,Q14155,P42345,Q96EB6,Q13501,Q14683,P09601,O76024,O00429 11 |
| Vitamin d in inflammatory diseases 0.2924948086621275 0.1496286005166873 0.8810576422543117 1.0 0.9759050658903488 4 Q08209,Q16539,P19838 3 |
| Proximal tubule transport 0.3069068270976852 0.142135792185919 0.8869727470934679 1.0 0.9769554895522254 11 P08195,Q9UI12 2 |
| Nocgmppkg mediated neuroprotection 0.3302814192039783 0.1301088138503142 0.8964803369544141 1.0 0.979433034121794 7 P30536 1 |
| Nucleotide metabolism 0.2872023809523834 0.129835486586353 0.8966965862980727 1.0 0.979433034121794 15 P00374,P09884,P19623,P11908,P20839,P00492,P22392,P30566,P13995,P54098,P23921,P28340,P30520,P31350 14 |
| Dna replication 0.2587019607122342 0.1206598025650935 0.9039604992082784 1.0 0.97971337055561 32 Q9UBD5,P41440,O43913,P49005 4 |
| Endothelin pathways 0.3132983700061 0.119146172446516 0.905159550924385 1.0 0.97971337055561 9 P00403,Q02750 2 |
| Osteoblast differentiation and related diseases 0.3060921248142668 0.1190398438856023 0.905243789335481 1.0 0.97971337055561 10 Q16539,P17252,Q06330,O00443,P78527,Q99570,P42224,P27361,P35222 9 |
| Tlr4 signaling and tolerance 0.3294073613405297 0.1175915148813869 0.9063913284420756 1.0 0.97971337055561 6 Q13546,Q15629 2 |
| Omega3 omega6 fatty acid synthesis 0.3265063817156484 0.1117681303419658 0.9110072574558528 1.0 0.9803405531560327 6 O60488,O95864,P33121,Q15067,O15254 5 |
| Vitamin dsensitive calcium signaling in depression 0.3215366050722397 0.1021463328242034 0.9186405250422498 1.0 0.9850967386268116 6 P00390 1 |
| Hedgehog signaling pathway wp4249 0.2934718100890312 0.0969933573165089 0.9227316696710172 1.0 0.9850967386268116 5 Q13618,Q9Y496,P17252,P48729 4 |
| Tnfalpha signaling pathway 0.2590873644084928 0.0959904057688034 0.923528192462636 1.0 0.9850967386268116 22 P63000,Q12933,Q13546,P19838,P42574,P53350,Q9NR28,Q9UHD2 8 |
| Il18 signaling pathway 0.2353677532769001 0.0926447943475333 0.9261857560110096 1.0 0.9859755577795044 58 P49841,Q9HC07,P50416,Q16836 4 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.3059103059102942 0.0896851166322193 0.9285374434821564 1.0 0.9859755577795044 8 Q16539,P19838,P17252,Q13555,Q96JM3,P42224,P27361 7 |
| Fgfr3 signaling in chondrocyte proliferation and terminal differentiation 0.3058194774346787 0.0807231454075901 0.9356621295083396 1.0 0.9859755577795044 7 Q16539,Q02750,P09543,P42224,P27361,P36507 6 |
| 7oxoc and 7betahc pathways 0.299426476375573 0.0771901039138705 0.938472314091459 1.0 0.9859755577795044 8 Q9Y305,O14734 2 |
| Estrogen signaling pathway 0.2935589195607046 0.0562675829573308 0.9551286429582216 1.0 0.9952320916791756 6 Q16539,P19838,P17252,P28482,Q02750 5 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.2726462726462703 0.0346454875706311 0.9723624294176564 1.0 1.0 8 P28482,Q02750,P42345,Q13131,P27361,Q96KB5,P36507 7 |
| Amyotrophic lateral sclerosis als 0.2586206896551676 0.0315488572345323 0.97483182907841 1.0 1.0 11 P63000,O96008,Q16539,P04637,Q08209,P07196,P42574,P20339,Q9BUN8,P36507 10 |
| Vitamin d receptor pathway 0.2496588887489274 0.0250522452181321 0.9800132910085656 1.0 1.0 13 P24941 1 |
| Brainderived neurotrophic factor bdnf signaling pathway 0.236238661511567 0.0239358861434644 0.980903749472863 1.0 1.0 43 P49841,Q96S59,Q15418 3 |
| Arrhythmogenic right ventricular cardiomyopathy 0.2455217695065639 0.0177416126951816 0.9858449837341928 1.0 1.0 13 Q02487,P19022 2 |
| Bladder cancer 0.2585785100881538 0.0175611454145348 0.985988953360815 1.0 1.0 6 P11802 1 |
| Splicing factor nova regulated synaptic proteins 0.2374935945367393 0.0043902290837466 0.996497115248193 1.0 1.0 15 P19022,Q13555,O14936 3 |
| Focal adhesion 0.2312909512558481 0.0026200538846553 0.9979095018487298 1.0 1.0 38 P49841,Q13464,P31751 3 |
|
|
